HCV & Substance Misuse

HCV Screening and Linkage to Care: The Norton Experience

Activity Details
  • Credit Amounts:
    • CME: 0.50
    • Other: 0.50
    • CDE: 0.50
  • Cost: Free
  • Release: Sep 4, 2019
  • Expires: Sep 3, 2022
  • Estimated Time to Complete:
    30 Minutes
  • System Requirements:
  • Average User Rating:
    ( Ratings)

Faculty

Jeffrey S.  Reeves Jeffrey S. Reeves, MD
Staff Physician
Norton Infectious Disease Specialist
Norton Healthcare
Louisville, Kentucky

Needs Statement

Current CDC guidelines recommend universal screening of patients born between 1945 and 1965 as well as other patients based on risk.

All eligible patients are not being screened and patients with risky exposures/behaviors are difficult to link to care.

This activity has been approved by the KBML as meeting the statutory requirements of HB1.

Target Audience

Health care providers who want to identify at-risk patients and link them to care.

Objectives

Upon completion of this education activity, participants will be able to:

  • Identify the patients at risk for HCV in Kentucky
  • Outline best practices for HCV screening and linkage to care in Kentucky

Accreditation

CME
The University of Kentucky College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Kentucky College of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The University of Kentucky College of Medicine presents this activity for educational purposes only. Participants are expected to utilize their own expertise and judgment while engaged in the practice of medicine. The content of the presentations is provided solely by presenters who have been selected for presentations because of recognized expertise in their field.

This training has been approved by the KBML as meeting the statutory requirements of HB1.

ACGME Competencies

  • Patient care
  • Medical knowledge

Other
UK Healthcare CECentral certifies this activity for 0.50 hours of participation.

CDE
This online course meets regulatory requirements for 0.50 hours credit as permitted by 201 KAR 8:532 for dentists and 201 KAR 8:562 for dental hygienists.

Faculty Disclosure

Dr. Reeves (speaker) has relevant financial relationships with commercial interests as follows:

  • Gilead Sciences, Inc. - Principal Investigator - Reimbursement for time spent on research for grant-related activities

No planners have any relevant financial relationships to disclose.

The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speaker. In some cases, the presentation might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. The speaker will inform the audience when they are discussing investigational and/or off-label uses.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Acknowledgement

In collaboration with Kentucky Aids Education Training Center and Kentucky Injury Prevention and Research Center University of Kentucky College of Public Health.

CE Content Concerns

Policy

Concerns or complaints related to ACPE or ACCME standards may be submitted in writing to the Director of UK HealthCare CECentral by fax to 859-323-2920, or by mail to 2365 Harrodsburg Road, Ste B475, Lexington, KY 40504

Procedures

  • The Director or his/her designee will review, investigate, forward and/or respond to complaints and will put forth a best effort to adjudicate the issue(s), along with CECentral staff members, within two (2) weeks of receipt of the grievance or complaint.
  • If needed, concerns, complaints, or grievances will be brought before the UK HealthCare CECentral Advisory Board.
  • Issues regarding activity content also will be reviewed and addressed by the Activity Director.
  • A written decision will be issued in a timely manner by the Director of UK HealthCare CECentral or his/herdesignee.
  • Grievances will be considered when planning future activities.

Appeal Procedure

  • Persons who wish to appeal a decision should address the appeal by email, fax or in writing to the Director of UK HealthCare CECentral within two (2) weeks of receipt of the response.
  • The Director will bring the appeal to the UK HealthCare CECentral Advisory Board.
  • The results of the appeal will be sent to the participant no later than two (2) weeks following the meeting of the board.